Tech Lead, Customer Success — Cloud-Native Architect

Vitrolife Group; Paterna; Hybrid; EUR 70,000 - 100,000; Full time

Benefits offered by this job

Hybrid working model

Private health insurance

Job summary

Vitrolife Group is seeking a Tech Lead to guide the Customer Success domain's technical direction, architecture, and delivery. You will balance pragmatic engineering with strong leadership, mentor developers, and collaborate with platform, security, and enterprise teams in a global setting.

Based in Parque Tecnológico, Paterna, Valencia, Spain, the role offers a hybrid working model, emphasis on secure, scalable solutions, and the chance to influence long-term health-tech products while

Qualifications

• Strong hands-on experience as a senior engineer or technical lead.
• Solid understanding of cloud-native architectures and integrations.
• Ability to make clear technical decisions and explain trade-offs.

Responsibilities

• Design and evolve the technical architecture of the product.
• Break down features into technical tasks and concrete implementation approaches.
• Lead sprint planning and technical refinement.
• Ensure CI/CD and operational practices are in place.
• Collaborate with platform, security, and enterprise architecture teams.
• Mentor developers and raise the technical bar across the team.
• Identify and mitigate technical risks, dependencies, and debt.
• Support incident resolution and root cause analysis.

Skills

Senior engineer

Technical lead

Cloud-native

Agile

Decision making

Tools

Docker

Kubernetes

Azure Container Apps

Observability tools

Job description

Vitrolife Group is seeking a Tech Lead to guide the Customer Success domain's technical direction, architecture, and delivery. You will balance pragmatic engineering with strong leadership, mentor developers, and collaborate with platform, security, and enterprise teams in a global setting.

Based in Parque Tecnológico, Paterna, Valencia, Spain, the role offers a hybrid working model, emphasis on secure, scalable solutions, and the chance to influence long-term health-tech products while